Comparative Study Of Domestic OMOM And Imported GIVEN Capsule Endoscopy

Objective:By the clinical pathway management,to compare and study the safety and efficacy of domestic OMOM and imported GIVEN SB2 capsule endoscopy.Methods:From August 2013 to August 2016,the study included 67 subjects who acceptted the inspection of capsule endoscopy.According to the principle of voluntary choice,the types of capsule endoscopy were divided into two groups,among them,60 cases received OMOM capsule endoscopy,and the other received GIVEN SB2 capsule endoscopy.The two groups were completed according to the clinical pathway,after the inspection,the pictures from the recorder to the dedicated workstation were downloaded,two physicians independently reviewed the images,the gastric transit time and small intestinal transit time wererecorded,the rate of complete small bowel examination,lesion detection rate and positive rate of the two groups were calculated.Finally,the above indicators were compared.Results:1.In this study,the two groups were safely completed capsule endoscopy through the management of clinical pathway,the results were satisfactory,and no adverse events happended.2.Transit time: In the two groups,the average gastric transit time was 35.18±28.83 and 42 ± 49.04 min respectively,by the ‘t ’ test,P >0.05,without significant difference between the two groups;the average intestinal transit time was 229.82±113.95 and 149.86 ± 70.70 min respectively,by ‘t ’test,P >0.05,without significant difference between the two groups.3.Capsule endoscopy results: In the two groups,the gastroscopy intervention rate was 10% and 0 respectively,by the ‘Fisher’ test,P >0.05,without significant difference between the two groups;the completed examination rate of the small bowel was 98.33% and 100% respectivel,by the ‘Fisher’ test,P >0.05,without significant difference between the two groups;the detection rate of lesions was 85% and 71.43%respectively,by the ‘Fisher’ test,P >0.05,without significant difference between the two groups;the positive rates was 63.33% and 71.43%,respectively,by the ‘Fisher’ test,P >0.05,without significant difference between the two groups.Conclusion:1.The clinical pathway of the domestic OMOM capsule endoscopy is similar to the imported GIVEN SB2 capsule endoscopy in the diagnosis of small bowel disease,in the clinical application of high diagnostic value,safety and patient tolerance are good.2.The volume and weight of domestic OMOM CE is larger,but its price is cheaper,it passes through the stomach(pylorus)into the duodenum within 120 minutes of the intervention rate is higher.3.The imported GIVEN SB2 capsule endoscopy is smaller,lighter,more expensive,and it is better to pass through the stomach into the duodenum.4.There was no significant difference between the two groups in the mean time of small bowel operation,the rate of complete small bowel examination,the detection rate of lesions,and the positive detection rate.